MEDIUM confidence: 100% data completeness, but the composite (50) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider -$909K over 180 days (0 open-market buys, 3 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $150 (last qtr, 4 analysts) → $148 (last mo, 3) (-1.4%).
Buy-rated share 58% → 56% over ~3 months (-2pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.41 | $1.43 | +1.4% |
| Apr 2026 | $1.56 | $1.59 | +1.9% |
| Jan 2026 | $1.86 | $1.88 | +1.1% |
| Oct 2025 | $1.90 | $1.99 | +4.7% |
| Jul 2025 | $1.42 | $1.48 | +4.2% |
| Apr 2025 | $1.52 | $1.54 | +1.3% |
| Jan 2025 | $1.89 | $1.88 | -0.5% |
| Oct 2024 | $1.90 | $1.93 | +1.6% |
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $80.2B— | $82.0B+2.3% | $84.0B+2.5% | $84.3B+0.3% | $87.0B+3.3% |
| EPS (dil.) | $5.81— | $5.90+1.5% | $6.02+2.0% | $6.51+8.1% | $6.62+1.7% |
| Free Cash Flow | $13.6B— | $13.8B+1.6% | $16.5B+19.9% | $14.0B-15.0% | $15.9B+13.3% |
| Gross Margin | 47.4% | 47.9%+0.4pp | 51.4%+3.5pp | 51.2%-0.2pp | 50.2%-1.0pp |
| Operating Margin | 22.2% | 22.1%-0.1pp | 22.1%-0.0pp | 24.3%+2.2pp | 22.7%-1.6pp |
| Net Margin | 18.4% | 17.9%-0.5pp | 17.7%-0.2pp | 19.0%+1.2pp | 18.4%-0.5pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 1.5%/yr (revenue basis).
Base free cash flow $15.5B (avg FY2024–FY2026; latest year $15.9B) · equity value $342.3B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 50 indicates a neutral outlook for PG, driven by a mix of factors. The stock scores high on profitability, with a notable ROE of 29.8%, and exhibits relatively low risk, with a beta of 0.4. However, it trades at a premium, as reflected in its value score, and exhibits weak momentum, with a 12-month return of -7.3% and a bearish moving average trend. The long-term and short-term scores are moderately divergent, with the long-term score 4 points higher.